| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |